Patents by Inventor Wilfried DINH

Wilfried DINH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Supporting patients in the repeated taking of drugs
    Patent number: 11763924
    Abstract: The invention relates to the technical field of supporting patients in the repeated taking of drugs within the context of a therapeutic treatment. The invention relates to a method, to a system, and to a computer program product that monitor the taking of drugs by a patient and inform the patient or a doctor or another person if a drug portion should not be taken in order to thus optimize the effectiveness of the treatment or reduce risks.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: September 19, 2023
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hubert Trübel, Philip Patrick Böhme, Martin Van Eickels, Wilfried Dinh, Frank Kramer, Carlos Castellon
  • ACCOMPANYING CARDIAC INSUFFICIENCY PATIENTS
    Publication number: 20210085262
    Abstract: The present invention relates to the field of accompanying patients and alleviating the symptoms of a disease, particularly in patients suffering from cardiac insufficiency. The invention relates to a method and a system for monitoring the state of health of a large number of patients.
    Type: Application
    Filed: January 9, 2019
    Publication date: March 25, 2021
    Applicant: Bayer Aktiengesellschaft
    Inventors: Frank KRAMER, Wilfried DINH
  • ASSISTANCE IN THE TREATMENT OF CARDIAC INSUFFICIENCY
    Publication number: 20200337590
    Abstract: The present invention relates to the treatment of cardiac insufficiency. A sensor for measuring the tissue fluid content in the region of the rib cage is implanted in a person suffering from cardiac insufficiency. If the tissue fluid content does not get back to normal within a defined period of time and under treatment with the available standard therapy, treatment with a V1a/V2 vasopessin receptor antagonist is recommended. Dosage of the V1a/V2 vasopressin receptor antagonist and duration of the treatment with the V1a/V2 vasopressin receptor antagonist can be determined on the basis of the acquired sensor data.
    Type: Application
    Filed: January 10, 2019
    Publication date: October 29, 2020
    Applicant: Bayer Aktiengesellschaft
    Inventors: Frank KRAMER, Wilfried DINH, Daniel FORLER, Hubert TRÜBEL
  • SUPPORTING PATIENTS IN THE REPEATED TAKING OF DRUGS
    Publication number: 20200027540
    Abstract: The invention relates to the technical field of supporting patients in the repeated taking of drugs within the context of a therapeutic treatment. The invention relates to a method, to a system, and to a computer program product that monitor the taking of drugs by a patient and inform the patient or a doctor or another person if a drug portion should not be taken in order to thus optimize the effectiveness of the treatment or reduce risks.
    Type: Application
    Filed: March 16, 2018
    Publication date: January 23, 2020
    Applicant: Bayer Aktiengesellschaft
    Inventors: Hubert TRÜBEL, Philip Patrick BÖHME, Martin VAN EICKELS, Wilfried DINH, Frank KRAMER, Carlos CASTELLON